{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:25:09Z","timestamp":1794137109029,"version":"4.8.0"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.crmicr.2026.100651","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:02:32Z","timestamp":1784876552000},"page":"100651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bacterial neurotoxins: The snake venoms of the microbial world\u2014a clinical and bioengineering approach"],"prefix":"10.1016","volume":"11","author":[{"given":"Hanieh","family":"Banaeyoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Solhi Digehsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Golichenari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.crmicr.2026.100651_bib0001","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1111\/j.1742-4658.2011.08113.x","article-title":"Actin as target for modification by bacterial protein toxins","volume":"278","author":"Aktories","year":"2011","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.crmicr.2026.100651_bib0002","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrmicro2592","article-title":"Bacterial protein toxins that modify host regulatory GTPases","volume":"9","author":"Aktories","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0003","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrmicro1150","article-title":"Bacterial cytotoxins: targeting eukaryotic switches","volume":"3","author":"Aktories","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0165-6147(89)90191-0","article-title":"Botulinum ADP-ribosyltransferase C3: a new tool to study low molecular weight GTP-binding proteins","volume":"10","author":"Aktories","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.crmicr.2026.100651_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-micro-090816-093458","article-title":"Clostridium difficile toxin biology","volume":"71","author":"Aktories","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0006","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3390\/jcm14062021","article-title":"Botulinum toxin therapy: a comprehensive review on clinical and pharmacological insights","volume":"14","author":"Ayoub","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.crmicr.2026.100651_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108668","article-title":"Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain","volume":"259","author":"Bagues","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0008","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/IAI.66.4.1364-1369.1998","article-title":"The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin","volume":"66","author":"Barth","year":"1998","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0009","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/ph15060756","article-title":"Tetanus toxin fragment C: structure, drug discovery research and production","volume":"15","author":"Bayart","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.crmicr.2026.100651_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/toxins11090491","article-title":"Immunogenicity associated with botulinum toxin treatment","volume":"11","author":"Bellows","year":"2019","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0011","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s11307-024-01954-6","article-title":"Neurotoxin-derived optical probes for elucidating molecular and developmental biology of neurons and synaptic connections: toxin-derived optical probes for neuroimaging","volume":"26","author":"Bijjam","year":"2024","journal-title":"Mol. Imaging Biol."},{"issue":"6442","key":"10.1016\/j.crmicr.2026.100651_bib0012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25\u2032","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.crmicr.2026.100651_bib0013","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1111\/j.1742-4658.2011.08140.x","article-title":"Molecular basis of toxicity of Clostridium perfringens epsilon toxin","volume":"278","author":"Bokori-Brown","year":"2011","journal-title":"FEBS J"},{"issue":"12","key":"10.1016\/j.crmicr.2026.100651_bib0014","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.tibs.2006.10.002","article-title":"Epac proteins: multi-purpose cAMP targets","volume":"31","author":"Bos","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/toxins10100387","article-title":"Functional consequences of calcium influx promoted by bacterial pore-forming toxins","volume":"10","author":"Bouillot","year":"2018","journal-title":"Toxins"},{"issue":"S1","key":"10.1016\/j.crmicr.2026.100651_bib0016","article-title":"Botulinum neurotoxins: future innovations","volume":"102","author":"Brideau-Andersen","year":"2023","journal-title":"Med"},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0017","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/toxins16060266","article-title":"Update on non-interchangeability of botulinum neurotoxin products","volume":"16","author":"Brin","year":"2024","journal-title":"Toxins"},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0018","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.biocel.2007.07.005","article-title":"Vibrio cholerae: cholera toxin","volume":"39","author":"Vanden Broeck","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0019","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/fmb.09.133","article-title":"Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools","volume":"5","author":"Carbonetti","year":"2010","journal-title":"Fut. Microbiol."},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0020","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1007\/s12325-021-01882-9","article-title":"Immunogenicity of botulinum toxin formulations: potential therapeutic implications","volume":"38","author":"Carr","year":"2021","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-023-00369-7","article-title":"Clinical evidence of human pathogens implicated in Alzheimer\u2019s disease pathology and the therapeutic efficacy of antimicrobials: an overview","volume":"12","author":"Catumbela","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0022","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00253-015-7236-3","article-title":"Shiga toxins: from structure and mechanism to applications","volume":"100","author":"Chan","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0023","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","article-title":"Structure, function and drug discovery of GPCR signaling","volume":"4","author":"Cheng","year":"2023","journal-title":"Mol. Biomed."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0024","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.cdd.4400987","article-title":"Rho GTPase signalling pathways in the morphological changes associated with apoptosis","volume":"9","author":"Coleman","year":"2002","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0025","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0026","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache: J. Head Face Pain"},{"issue":"5773","key":"10.1016\/j.crmicr.2026.100651_bib0027","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0028","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev-biochem-013118-111654","article-title":"Botulinum and tetanus neurotoxins","volume":"88","author":"Dong","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"12","key":"10.1016\/j.crmicr.2026.100651_bib0029","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/toxins16120525","article-title":"Epsilon toxin from clostridium perfringens induces the generation of extracellular vesicles in HeLa cells overexpressing Myelin and lymphocyte protein","volume":"16","author":"Dorca-Ar\u00e9valo","year":"2024","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","volume":"15","author":"Dressler","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"issue":"23","key":"10.1016\/j.crmicr.2026.100651_bib0031","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/09638280701568296","article-title":"Pharmacology of therapeutic botulinum toxin preparations","volume":"29","author":"Dressler","year":"2007","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.crmicr.2026.100651_bib0032","first-page":"1","article-title":"Developing botulinum toxin drugs: unexpected challenges","author":"Dressler","year":"2026","journal-title":"J. Neural Transm."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0033","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00702-022-02494-5","article-title":"Botulinum toxin therapy: past, present and future developments","volume":"129","author":"Dressler","year":"2022","journal-title":"J. Neural Transm."},{"issue":"9","key":"10.1016\/j.crmicr.2026.100651_bib0034","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70593","article-title":"The microbiota-gut-brain connection: a new horizon in neurological and neuropsychiatric disorders","volume":"31","author":"Faysal","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.crmicr.2026.100651_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.760403","article-title":"Direct inhibition of microglia activation by pretreatment with botulinum neurotoxin A for the prevention of neuropathic pain","volume":"15","author":"Feng","year":"2021","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0036","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1023348708599","article-title":"The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep","volume":"27","author":"Fernandez Miyakawa","year":"2003","journal-title":"Vet. Res. Commun."},{"issue":"16","key":"10.1016\/j.crmicr.2026.100651_bib0037","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.3390\/ijms23169050","article-title":"Pathology and pathogenesis of brain lesions produced by Clostridium perfringens type D epsilon toxin","volume":"23","author":"Finnie","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0038","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/toxins10050208","article-title":"The expanding therapeutic utility of botulinum neurotoxins","volume":"10","author":"Fonfria","year":"2018","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0039","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10408418409105905","article-title":"ADP-ribosylating microbial toxins","volume":"11","author":"Foster","year":"1984","journal-title":"CRC Crit. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.toxicon.2009.01.037","article-title":"Engineered toxins: new therapeutics","volume":"54","author":"Foster","year":"2009","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0041","first-page":"2715","article-title":"A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: an international group consensus","volume":"53","author":"Francisco","year":"2020","journal-title":"J. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0042","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"14","key":"10.1016\/j.crmicr.2026.100651_bib0043","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1016\/j.febslet.2006.04.100","article-title":"Cellular stability of rho-GTPases glucosylated by Clostridium difficile toxin B","volume":"580","author":"Genth","year":"2006","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.crmicr.2026.100651_bib0044","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ejcb.2010.10.009","article-title":"Functional implications of lethal toxin-catalysed glucosylation of (H\/K\/N) Ras and Rac1 in Clostridium sordellii-associated disease","volume":"90","author":"Genth","year":"2011","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.crmicr.2026.100651_bib0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/978-1-4419-6327-7_5","article-title":"Cholesterol-dependent cytolysins","volume":"677","author":"Gilbert","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5800","key":"10.1016\/j.crmicr.2026.100651_bib0046","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0047","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/cdd.2017.49","article-title":"Pore-forming toxin-mediated ion dysregulation leads to death receptor-independent necroptosis of lung epithelial cells during bacterial pneumonia","volume":"24","author":"Gonz\u00e1lez-Juarbe","year":"2017","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0048","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/biomedicines5020028","article-title":"Addressing the immunogenicity of the cargo and of the targeting antibodies with a focus on demmunized bacterial toxins and on antibody-targeted Human effector proteins","volume":"5","author":"Grinberg","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.crmicr.2026.100651_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107209","article-title":"Botulinum toxin in the management of parkinsonian disorders","volume":"232","author":"Grippe","year":"2023","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/09687680410001663267","article-title":"Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms","volume":"21","author":"Haan","year":"2004","journal-title":"Mol. Membr. Biol."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0051","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","article-title":"Immune signaling in neurodegeneration","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0052","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40259-023-00641-2","article-title":"Reducing immunogenicity by design: approaches to minimize immunogenicity of monoclonal antibodies","volume":"38","author":"Harris","year":"2024","journal-title":"BioDrugs : Clin. Immunother. Biopharm. Gene Ther."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0053","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/toxins5010073","article-title":"Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms","volume":"5","author":"Hassel","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.crmicr.2026.100651_bib0054","series-title":"Botulinum Neurotoxins","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes","author":"Hill","year":"2012"},{"issue":"6286","key":"10.1016\/j.crmicr.2026.100651_bib0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.crmicr.2026.100651_bib0056","series-title":"Pore-forming Toxins During Bacterial infection: Molecular Mechanisms and Potential Therapeutic Targets\u2019","first-page":"3773","author":"Hu","year":"2021"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0057","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41580-023-00668-x","article-title":"Mechanisms of SNARE proteins in membrane fusion","volume":"25","author":"Jahn","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7419","key":"10.1016\/j.crmicr.2026.100651_bib0058","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11320","article-title":"Molecular machines governing exocytosis of synaptic vesicles","volume":"490","author":"Jahn","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.crmicr.2026.100651_bib0059","article-title":"Effects of botulinum toxin on pain control mechanisms, muscle structure and cortical reorganization, a mini-review","volume":"260","author":"Jahromi","year":"2025","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0060","doi-asserted-by":"crossref","first-page":"G86","DOI":"10.1152\/ajpgi.1993.264.1.G86","article-title":"Cholera toxin-sensitive neurons in guinea pig submucosal plexus","volume":"264","author":"Jiang","year":"1993","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.crmicr.2026.100651_bib0061","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2018.12.002","article-title":"Use of botulinum toxin in Parkinson\u2019s disease","volume":"59","author":"Jocson","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0062","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga toxins\u2014From cell biology to biomedical applications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0063","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/toxins12020067","article-title":"Shiga toxin-associated hemolytic uremic syndrome: a narrative review","volume":"12","author":"Joseph","year":"2020","journal-title":"Toxins"},{"issue":"6531","key":"10.1016\/j.crmicr.2026.100651_bib0064","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/375500a0","article-title":"Glucosylation of Rho proteins by Clostridium difficile toxin B","volume":"375","author":"Just","year":"1995","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.crmicr.2026.100651_bib0065","doi-asserted-by":"crossref","first-page":"13932","DOI":"10.1074\/jbc.270.23.13932","article-title":"The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho Proteins\u2217","volume":"270","author":"Just","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0066","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cells8060591","article-title":"Rho GTPases in the physiology and pathophysiology of peripheral sensory neurons","volume":"8","author":"Kalpachidou","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0067","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41583-024-00806-0","article-title":"Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases","volume":"25","author":"Kampmann","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.crmicr.2026.100651_bib0068","series-title":"Principles of Neural Science","author":"Kandel","year":"2000"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0069","first-page":"24","article-title":"Neuroimmune regulation in autoimmune hemolytic anemia: a missing link in disease persistence and relapse","volume":"2","author":"Khatab","year":"2025","journal-title":"Arch. Med. Rep."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12964-024-01791-8","article-title":"Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways","volume":"22","author":"Kosz\u0142a","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0071","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/toxins11010015","article-title":"Evolutionary features in the structure and function of bacterial toxins","volume":"11","author":"Kumar","year":"2019","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2022.107876","article-title":"Elucidation of critical pH-dependent structural changes in botulinum neurotoxin E","volume":"214","author":"Lalaurie","year":"2022","journal-title":"J. Struct. Biol."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0073","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0092-8674(00)81371-9","article-title":"Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK\/SAPK MAP kinase cascade","volume":"87","author":"Lamarche","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0074","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00232-022-00227-z","article-title":"Membrane dynamics and remodelling in response to the action of the membrane-damaging pore-forming toxins","volume":"255","author":"Lata","year":"2022","journal-title":"J. Membr. Biol."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/toxins13020128","article-title":"Structural basis of the pore-forming toxin\/membrane interaction","volume":"13","author":"Li","year":"2021","journal-title":"Toxins"},{"issue":"7638","key":"10.1016\/j.crmicr.2026.100651_bib0076","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0077","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.02513-14","article-title":"Clostridium perfringens epsilon toxin causes selective death of mature oligodendrocytes and central nervous system demyelination","volume":"6","author":"Linden","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.crmicr.2026.100651_bib0078","article-title":"Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0079","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/toxins15030176","article-title":"Pasteurian contributions to the study of bordetella pertussis toxins","volume":"15","author":"Locht","year":"2023","journal-title":"Toxins"},{"issue":"23","key":"10.1016\/j.crmicr.2026.100651_bib0080","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1111\/j.1742-4658.2011.08237.x","article-title":"The ins and outs of pertussis toxin","volume":"278","author":"Locht","year":"2011","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0081","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0082","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/MMBR.00052-12","article-title":"Role of pore-forming toxins in bacterial infectious diseases","volume":"77","author":"Los","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0083","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/toxins14100704","article-title":"Botulinum neurotoxins beyond neurons: interplay with glial cells","volume":"14","author":"Luvisetto","year":"2022","journal-title":"Toxins"},{"issue":"9","key":"10.1016\/j.crmicr.2026.100651_bib0084","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163239","article-title":"Epsilon toxin\u2013producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege","volume":"133","author":"Ma","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.crmicr.2026.100651_bib0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/toxins3070884","article-title":"Gi\/o protein-dependent and-independent actions of pertussis toxin (PTX)","volume":"3","author":"Mangmool","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.crmicr.2026.100651_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2025.108250","article-title":"BoNT\/action beyond neurons","volume":"255","author":"Marinelli","year":"2025","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0087","first-page":"1","article-title":"The role of gut-derived neurotransmitters in the pathogenesis of autoimmune neurological disorders","volume":"2","author":"Marra","year":"2025","journal-title":"Arch. Med. Rep."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0088","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/toxins16020101","article-title":"Complexing protein-free botulinum neurotoxin A formulations: implications of excipients for immunogenicity","volume":"16","author":"Martin","year":"2024","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0089","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pharmtox-011613-135935","article-title":"Engineered botulinum neurotoxins as new therapeutics","volume":"54","author":"Masuyer","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.crmicr.2026.100651_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107452","article-title":"Structure-based design of a botulinum neurotoxin with triple receptor recognition","volume":"237","author":"Masuyer","year":"2024","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0091","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.EHEC-0024-2013","article-title":"Shiga toxin (Stx) classification, structure, and function","volume":"2","author":"Melton-Celsa","year":"2014","journal-title":"Microbiol. Spectr."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0092","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00164-22","article-title":"Bordetella bronchiseptica and Bordetella pertussis: similarities and differences in infection, immuno-modulation, and vaccine considerations","volume":"36","author":"Miguelena Chamorro","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.crmicr.2026.100651_bib0093","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70187","article-title":"Botulinum neurotoxins: history, mechanism, and applications. A narrative review","volume":"169","author":"Monash","year":"2025","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0094","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota\u2013brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/toxins12050330","article-title":"Neuroprotective fragment C of tetanus toxin modulates IL-6 in an ALS mouse model","volume":"12","author":"Moreno-Martinez","year":"2020","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0096","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0097","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41579-024-01116-z","article-title":"Streptococcus pneumoniae epidemiology, pathogenesis and control","volume":"23","author":"Narciso","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"5573","key":"10.1016\/j.crmicr.2026.100651_bib0098","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0099","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/neu.20153","article-title":"Rho GTPases, dendritic structure, and mental retardation","volume":"64","author":"Newey","year":"2005","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.crmicr.2026.100651_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2164(10)71001-7","article-title":"Influence of Escherichia coli shiga toxin on the mammalian central nervous system","volume":"71","author":"Obata","year":"2010","journal-title":"Adv. Appl. Microbiol."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/MMBR.00064-21","article-title":"Large clostridial toxins: mechanisms and roles in disease","volume":"85","author":"Orrell","year":"2021","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0102","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/ph17030310","article-title":"Effect of botulinum toxin injections in the treatment of spasticity of different etiologies: an umbrella review","volume":"17","author":"Otero-Luis","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0103","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00018-013-1380-7","article-title":"The blockade of the neurotransmitter release apparatus by botulinum neurotoxins","volume":"71","author":"Pantano","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/toxins9100319","article-title":"Shiga toxins induce apoptosis and ER stress in human retinal pigment epithelial cells","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12640-018-9990-3","article-title":"Effectiveness of fragment C domain of tetanus toxin and pramipexole in an animal model of Parkinson\u2019s disease","volume":"35","author":"Patricio","year":"2019","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0106","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/toxins9010038","article-title":"Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature","volume":"9","author":"Peck","year":"2017","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.00089-18","article-title":"The light chain defines the duration of action of botulinum toxin serotype A subtypes","volume":"9","author":"Pellett","year":"2018","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrmicro.2015.3","article-title":"Pore-forming toxins: ancient, but never really out of fashion","volume":"14","author":"Peraro","year":"2016","journal-title":"Nat. rev. microbiol."},{"key":"10.1016\/j.crmicr.2026.100651_bib0109","unstructured":"Petrovi\u0107, M. (no date) \u2018Mechanisms and consequences of neuroinflammation following Streptococcus pneumoniaeinfection: implications for synaptic function\u2019."},{"key":"10.1016\/j.crmicr.2026.100651_bib0110","series-title":"Neuroscience in the 21st century: from Basic to Clinical","author":"Pfaff","year":"2022"},{"key":"10.1016\/j.crmicr.2026.100651_bib0111","series-title":"Trending Topics in Escherichia coli Research: the Latin American Perspective","first-page":"177","article-title":"Shiga toxin and its effect on the central nervous system","author":"Pinto","year":"2023"},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0112","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.celrep.2014.08.017","article-title":"Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins","volume":"8","author":"Pirazzini","year":"2014","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0113","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0114","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.28209","article-title":"Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host","volume":"5","author":"Popoff","year":"2014","journal-title":"Small GTPases"},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/toxins16040182","article-title":"Overview of bacterial protein toxins from pathogenic bacteria: mode of action and insights into evolution","volume":"16","author":"Popoff","year":"2024","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/toxins18010035","article-title":"Advances in clostridial neurotoxins: passage of the intestinal barrier and targeting of specific neuronal cells","volume":"18","author":"Popoff","year":"2026","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0117","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/toxins2040683","article-title":"Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells","volume":"2","author":"Popoff","year":"2010","journal-title":"Toxins"},{"issue":"6301","key":"10.1016\/j.crmicr.2026.100651_bib0118","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0119","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/toxins16060261","article-title":"Embracing the versatility of botulinum neurotoxins in conventional and new therapeutic applications","volume":"16","author":"Rasetti-Escargueil","year":"2024","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0121","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cell.2010.11.019","article-title":"Pathogen-mediated posttranslational modifications: a re-emerging field","volume":"143","author":"Ribet","year":"2010","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.crmicr.2026.100651_bib0122","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1021\/acs.accounts.5b00403","article-title":"How lipid membranes affect pore forming toxin activity","volume":"48","author":"Rojko","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.crmicr.2026.100651_bib0123","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-540-74805-2_6","article-title":"Presynaptic neurotoxins with enzymatic activities","author":"Rossetto","year":"2008","journal-title":"Pharmacol. Neurotransm. Release"},{"issue":"8","key":"10.1016\/j.crmicr.2026.100651_bib0124","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.crmicr.2026.100651_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004896","article-title":"The myelin and lymphocyte protein MAL is required for binding and activity of Clostridium perfringens \u03b5-toxin","volume":"11","author":"Rumah","year":"2015","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0609713104","article-title":"Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept","volume":"104","author":"Rummel","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0127","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11940-018-0488-3","article-title":"Botulinum toxin treatment of movement disorders","volume":"20","author":"Safarpour","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"issue":"9","key":"10.1016\/j.crmicr.2026.100651_bib0128","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"S\u00e1nchez","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cellbio.18.011502.142107","article-title":"Membrane traffic exploited by protein toxins","volume":"18","author":"Sandvig","year":"2002","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acs.accounts.0c00551","article-title":"Mechanistic insights into pore Formation by an \u03b1-pore forming toxin: protein and lipid bilayer interactions of cytolysin A","volume":"54","author":"Sathyanarayana","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0131","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.94.3.997","article-title":"Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses","volume":"94","author":"Schiavo","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0132","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0133","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cell.2014.02.007","article-title":"The interdependence of membrane shape and cellular signal processing","volume":"156","author":"Schmick","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.crmicr.2026.100651_bib0134","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/vaccines13121237","article-title":"Toward universal protection: a comprehensive review of pneumococcal disease, emerging vaccination challenges and future perspectives","volume":"13","author":"Sgrulletti","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.crmicr.2026.100651_bib0135","article-title":"Molecular mechanisms of streptococcal disruption of the blood-brain barrier and their pathogenic role in bacterial meningitis","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0136","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10286-021-00787-5","article-title":"Peripheral neuroimmune interactions: selected review and some clinical implications","volume":"31","author":"Shouman","year":"2021","journal-title":"Clin. Auton. Res."},{"issue":"30","key":"10.1016\/j.crmicr.2026.100651_bib0137","doi-asserted-by":"crossref","first-page":"21145","DOI":"10.1074\/jbc.M800610200","article-title":"Substrate recognition mechanism of VAMP\/synaptobrevin-cleaving clostridial neurotoxins","volume":"283","author":"Sikorra","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.crmicr.2026.100651_bib0138","series-title":"Shiga toxins: a review of structure, mechanism, and detection","author":"Silva","year":"2017"},{"issue":"9","key":"10.1016\/j.crmicr.2026.100651_bib0139","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrmicro3310","article-title":"Novel bacterial ADP-ribosylating toxins: structure and function","volume":"12","author":"Simon","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"19","key":"10.1016\/j.crmicr.2026.100651_bib0140","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED] report of the guideline development subcommittee of the American academy of neurology\u2019","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.crmicr.2026.100651_bib0141","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0142","first-page":"118","article-title":"Structure and mechanism of action of botulinum and tetanus neurotoxins: a review","volume":"28","author":"Skryabina","year":"2023","journal-title":"Epidemiol. Infect. Dis."},{"issue":"13","key":"10.1016\/j.crmicr.2026.100651_bib0143","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426745122","article-title":"Targeted degradation of \u03b1-synuclein using an evolved botulinum toxin protease","volume":"122","author":"Sondermann","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0144","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00338-20","article-title":"A comprehensive review on the role of the gut microbiome in human neurological disorders","volume":"35","author":"Sorboni","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0145","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/mr.56.4.622-647.1992","article-title":"Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin","volume":"56","author":"Spangler","year":"1992","journal-title":"Microbiol. Rev."},{"issue":"11","key":"10.1016\/j.crmicr.2026.100651_bib0146","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3390\/toxins5112138","article-title":"Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?","volume":"5","author":"Stiles","year":"2013","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0147","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2013.10.022","article-title":"Neurotransmitter release: the last millisecond in the life of a synaptic vesicle","volume":"80","author":"S\u00fcdhof","year":"2013","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0148","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/toxins16020098","article-title":"Best practice guidelines for the management of patients with post-stroke spasticity: a modified scoping review","volume":"16","author":"Suputtitada","year":"2024","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0149","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/toxins18030148","article-title":"Mechanisms of pertussis toxin action: aDP-ribosylation and its role in pertussis pathogenesis","volume":"18","author":"Tang","year":"2026","journal-title":"Toxins"},{"issue":"7628","key":"10.1016\/j.crmicr.2026.100651_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0151","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1099\/mic.0.001154","article-title":"Bacterial pore-forming toxins","volume":"168","author":"Ulhuq","year":"2022","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0152","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/fmb.13.168","article-title":"Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease","volume":"9","author":"Uzal","year":"2014","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0153","doi-asserted-by":"crossref","DOI":"10.1038\/srep42923","article-title":"Engineering botulinum neurotoxin C1 as a molecular vehicle for intra-neuronal drug delivery","volume":"7","author":"Vazquez-Cintron","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmicr.2026.100651_bib0154","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2021.735819","article-title":"Changes in cortical activity in stroke survivors undergoing botulinum neurotoxin therapy for treatment of focal spasticity","volume":"2","author":"Vinehout","year":"2021","journal-title":"Front. Rehabil. Sci."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","article-title":"Clostridium difficile toxins: mechanism of action and role in disease","volume":"18","author":"Voth","year":"2005","journal-title":"Clin. Microbiol,. Rev."},{"issue":"9","key":"10.1016\/j.crmicr.2026.100651_bib0156","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/toxins17090453","article-title":"Research progress on the detection methods of botulinum neurotoxin","volume":"17","author":"Wang","year":"2025","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0157","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13578-020-00501-4","article-title":"Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2\/MyD88 and SNAP23","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.crmicr.2026.100651_bib0158","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/toxins10060231","article-title":"Engineering of botulinum neurotoxins for biomedical applications","volume":"10","author":"Webb","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.crmicr.2026.100651_bib0159","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.828427","article-title":"Cell-penetrating botulinum neurotoxin type A with improved cellular uptake and therapeutic index","volume":"10","author":"Wei","year":"2022","journal-title":"Front Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.crmicr.2026.100651_bib0160","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2217\/fmb.10.91","article-title":"Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins","volume":"5","author":"Wilson","year":"2010","journal-title":"Fut. Microbiol."},{"key":"10.1016\/j.crmicr.2026.100651_bib0161","series-title":"G ProteinsTechniques of Analysis","first-page":"173","article-title":"ADP-ribosylation of G proteins with cholera toxin or pertussis toxin","author":"Woolkalis","year":"2020"},{"issue":"12","key":"10.1016\/j.crmicr.2026.100651_bib0162","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","article-title":"Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014An update","volume":"46","author":"Wu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.crmicr.2026.100651_bib0163","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bsheal.2019.09.004","article-title":"Clostridium perfringens epsilon toxin: toxic effects and mechanisms of action","volume":"1","author":"Xin","year":"2019","journal-title":"Biosaf. Health"},{"issue":"10","key":"10.1016\/j.crmicr.2026.100651_bib0164","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/BCJ20253088","article-title":"GPCR signaling via cAMP nanodomains","volume":"482","author":"Yadav","year":"2025","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.crmicr.2026.100651_bib0165","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3390\/ijms24032852","article-title":"Blood\u2013brain barrier integrity damage in bacterial meningitis: the underlying link, mechanisms, and therapeutic targets\u2019","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9S","key":"10.1016\/j.crmicr.2026.100651_bib0166","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/DSS.0000000000004346","article-title":"New and future developments in neurotoxins","volume":"50","author":"Yoelin","year":"2024","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0167","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0168","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/toxins16040175","article-title":"Recent developments in engineering non-paralytic botulinum molecules for therapeutic applications","volume":"16","author":"Zhantleuova","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.crmicr.2026.100651_bib0169","article-title":"The role of pertussis toxin in clinical manifestations of pertussis","author":"Zhao","year":"2025","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.crmicr.2026.100651_bib0170","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s11481-019-09866-x","article-title":"Neuroprotective effects of genistein in a SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"14","author":"Zhao","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.crmicr.2026.100651_bib0171","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/toxins15010018","article-title":"Neurotoxins acting at synaptic sites: a brief review on mechanisms and clinical applications","volume":"15","author":"Zhou","year":"2022","journal-title":"Toxins"}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517426001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517426001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:48:12Z","timestamp":1794134892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666517426001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":171,"alternative-id":["S2666517426001070"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2026.100651","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacterial neurotoxins: The snake venoms of the microbial world\u2014a clinical and bioengineering approach","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2026.100651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100651"}}